The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in patients with cystic fibrosis (CF) has been well established. Few data are available on the value of continuous alternating inhaled antibiotic therapy (CAIT), a strategy increasingly used in the management of CF.publisher: Elsevier articletitle: Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis journaltitle: Journal of Cystic Fibrosis articlelink: http://dx.doi.org/10.1016/j.jcf.2016.09.002 content_type: article copyright: © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.status: publishe
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas a...
Introduction: CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with...
Purpose: In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium, aztreonam, and levo-fl...
The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in p...
Cystic Fibrosis (CF) is the most frequent lethal inherited disease in the white population. In CF pa...
BACKGROUND: Cystic fibrosis is a multi-system disease characterised by the production of thick secre...
Purpose: In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium, aztreonam, and levo-fl...
Chronic airway infection in cystic fibrosis (CF) is a main cause of the increased morbidity and mort...
Background/Aims: In cystic fibrosis (CF), chronic microbial lung infections are difficult to treat...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
AbstractBackgroundVarious inhaled antibiotics are currently used for treating chronic Pseudomonas ae...
seudomonas aeruginosa remains the most common and significant pathogen for people with cystic fibros...
RATIONALE: For patients with cystic fibrosis (CF), the use of inhaled antibiotics has become standar...
SummaryThe use of inhaled therapies for chronic respiratory infections in cystic fibrosis represents...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas a...
Introduction: CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with...
Purpose: In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium, aztreonam, and levo-fl...
The efficacy of inhaled antibiotics to treat chronic Pseudomonas aeruginosa pulmonary infection in p...
Cystic Fibrosis (CF) is the most frequent lethal inherited disease in the white population. In CF pa...
BACKGROUND: Cystic fibrosis is a multi-system disease characterised by the production of thick secre...
Purpose: In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium, aztreonam, and levo-fl...
Chronic airway infection in cystic fibrosis (CF) is a main cause of the increased morbidity and mort...
Background/Aims: In cystic fibrosis (CF), chronic microbial lung infections are difficult to treat...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
AbstractBackgroundVarious inhaled antibiotics are currently used for treating chronic Pseudomonas ae...
seudomonas aeruginosa remains the most common and significant pathogen for people with cystic fibros...
RATIONALE: For patients with cystic fibrosis (CF), the use of inhaled antibiotics has become standar...
SummaryThe use of inhaled therapies for chronic respiratory infections in cystic fibrosis represents...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
The optimal antibiotic regimen is unclear in management of pulmonary infections due to pseudomonas a...
Introduction: CF pulmonary guidelines recommend alternate therapy (one month on, one month off) with...
Purpose: In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium, aztreonam, and levo-fl...